183 related articles for article (PubMed ID: 20185823)
21. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer.
Fujikane T; Nishikawa N; Toyota M; Suzuki H; Nojima M; Maruyama R; Ashida M; Ohe-Toyota M; Kai M; Nishidate T; Sasaki Y; Ohmura T; Hirata K; Tokino T
Breast Cancer Res Treat; 2010 Aug; 122(3):699-710. PubMed ID: 19859801
[TBL] [Abstract][Full Text] [Related]
22. The nuclear factor kappa B (NF-kappa B): a potential therapeutic target for estrogen receptor negative breast cancers.
Biswas DK; Dai SC; Cruz A; Weiser B; Graner E; Pardee AB
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10386-91. PubMed ID: 11517301
[TBL] [Abstract][Full Text] [Related]
23. 5-Aza-2'-deoxycytidine induces a greater inflammatory change, at the molecular levels, in normoxic than hypoxic tumor microenvironment.
Salviano Soares de Amorim Í; Rodrigues JA; Nicolau P; König S; Panis C; de Souza da Fonseca A; Mencalha AL
Mol Biol Rep; 2021 Feb; 48(2):1161-1169. PubMed ID: 33547534
[TBL] [Abstract][Full Text] [Related]
24. Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the β1-integrin-RhoA signaling axis.
Deevi RK; Cox OT; O'Connor R
Neoplasia; 2014 May; 16(5):422-31. PubMed ID: 24863845
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide methylation and expression profiling identifies promoter characteristics affecting demethylation-induced gene up-regulation in melanoma.
Rubinstein JC; Tran N; Ma S; Halaban R; Krauthammer M
BMC Med Genomics; 2010 Feb; 3():4. PubMed ID: 20144234
[TBL] [Abstract][Full Text] [Related]
26. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.
Nakshatri H; Bhat-Nakshatri P; Martin DA; Goulet RJ; Sledge GW
Mol Cell Biol; 1997 Jul; 17(7):3629-39. PubMed ID: 9199297
[TBL] [Abstract][Full Text] [Related]
27. PDLIM2 Is a Marker of Adhesion and β-Catenin Activity in Triple-Negative Breast Cancer.
Cox OT; Edmunds SJ; Simon-Keller K; Li B; Moran B; Buckley NE; Bustamante-Garrido M; Healy N; O'Flanagan CH; Gallagher WM; Kennedy RD; Bernards R; Caldas C; Chin SF; Marx A; O'Connor R
Cancer Res; 2019 May; 79(10):2619-2633. PubMed ID: 30885980
[TBL] [Abstract][Full Text] [Related]
28. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG
Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
[TBL] [Abstract][Full Text] [Related]
29. Nuclear factor-kappaB activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer.
Singh S; Shi Q; Bailey ST; Palczewski MJ; Pardee AB; Iglehart JD; Biswas DK
Mol Cancer Ther; 2007 Jul; 6(7):1973-82. PubMed ID: 17620428
[TBL] [Abstract][Full Text] [Related]
30. Suppression of NF-κB activation by PDLIM2 restrains hepatic lipogenesis and inflammation in high fat diet induced mice.
Hao YR; Tang FJ; Zhang X; Wang H
Biochem Biophys Res Commun; 2018 Sep; 503(2):564-571. PubMed ID: 29852170
[TBL] [Abstract][Full Text] [Related]
31. Induction of transforming growth factor-beta receptor type II expression in estrogen receptor-positive breast cancer cells through SP1 activation by 5-aza-2'-deoxycytidine.
Ammanamanchi S; Kim SJ; Sun LZ; Brattain MG
J Biol Chem; 1998 Jun; 273(26):16527-34. PubMed ID: 9632722
[TBL] [Abstract][Full Text] [Related]
32. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE
Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic regulation of MDR1 gene in breast cancer: CpG methylation status dominates the stable maintenance of a silent gene.
Sharma D; Vertino PM
Cancer Biol Ther; 2004 Jun; 3(6):549-50. PubMed ID: 15254426
[No Abstract] [Full Text] [Related]
34. Methylation-mediated regulation of the glutathione S-transferase P1 gene in human breast cancer cells.
Jhaveri MS; Morrow CS
Gene; 1998 Mar; 210(1):1-7. PubMed ID: 9524203
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasiveness.
Cheishvili D; Chik F; Li CC; Bhattacharya B; Suderman M; Arakelian A; Hallett M; Rabbani SA; Szyf M
Carcinogenesis; 2014 Nov; 35(11):2436-46. PubMed ID: 25178277
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic regulation of protein phosphatase 2A (PP2A), lymphotactin (XCL1) and estrogen receptor alpha (ER) expression in human breast cancer cells.
Keen JC; Garrett-Mayer E; Pettit C; Mack KM; Manning J; Herman JG; Davidson NE
Cancer Biol Ther; 2004 Dec; 3(12):1304-12. PubMed ID: 15662126
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic control of NF-κB-dependent FAS gene transcription during progression of myelodysplastic syndromes.
Ettou S; Humbrecht C; Benet B; Billot K; d'Allard D; Mariot V; Goodhardt M; Kosmider O; Mayeux P; Solary E; Fontenay M
Mol Cancer Res; 2013 Jul; 11(7):724-35. PubMed ID: 23604035
[TBL] [Abstract][Full Text] [Related]
38. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.
Woodfield GW; Hitchler MJ; Chen Y; Domann FE; Weigel RJ
Clin Cancer Res; 2009 Jun; 15(11):3672-9. PubMed ID: 19458056
[TBL] [Abstract][Full Text] [Related]
39. NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.
Nakshatri H; Appaiah HN; Anjanappa M; Gilley D; Tanaka H; Badve S; Crooks PA; Mathews W; Sweeney C; Bhat-Nakshatri P
Cell Death Dis; 2015 Jan; 6(1):e1608. PubMed ID: 25611383
[TBL] [Abstract][Full Text] [Related]
40. Exosome-mediated miR-222 transferring: An insight into NF-κB-mediated breast cancer metastasis.
Ding J; Xu Z; Zhang Y; Tan C; Hu W; Wang M; Xu Y; Tang J
Exp Cell Res; 2018 Aug; 369(1):129-138. PubMed ID: 29778754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]